Mepaco Medifood
Mepaco Medifood (Arab Company For Pharmaceuticals and Medicinal Plants) is an Egypt-based pharmaceutical manufacturer producing generic medicines, herbal remedies, supplements, and baby cereals across 12 therapeutic categories for export to approximately 30 countries in Asia, Africa, and Europe.
- Company typePrivate
- Founded-
- HeadquartersCairo, Egypt
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Mepaco Medifood does
Mepaco Medifood, legally registered as Arab Company For Pharmaceuticals and Medicinal Plants (MEPACO), is an Egypt-based pharmaceutical manufacturer headquartered in Cairo with a production facility in Enshas El Raml, Sharkeia Governorate, and an additional regional office in Alexandria. The company employs 501-1,000 people and operates under five international ISO certifications (9001:2015, 14001:2015, 45001:2018, 22000:2018, 17025:2017) covering quality, environmental, occupational health and safety, food safety, and laboratory competence. Its core technical capability is in herbal extraction, including volatile and fixed oils and in-house dry herbal extract production via a vacuum drying oven, which reduces dependence on imported raw materials.
The product portfolio spans over 100 SKUs across twelve therapeutic categories, including cardiovascular (angiotensin receptor blockers, Coenzyme Q10, L-Carnitine), antibiotics (amoxicillin-clavulanate, clindamycin, levofloxacin, nitrofurantoin), GIT products, NSAIDs and bone products, CNS medications, respiratory syrups, immune stimulants (echinacea-based), diabetic and diet control (metformin and herbal adjuncts), vitamins/minerals/antioxidants, urology, parasiticides, and a baby cereal line. The company also operates a Pharmacovigilance Department for adverse drug reaction monitoring across its marketed products.
Mepaco generates revenue through one-time sales of pharmaceutical and healthcare products distributed via pharmaceutical distribution networks, with exports to approximately 30 countries across Asia, Africa, and Europe. Pricing is not publicly disclosed; the company's stated positioning is "safe, effective and affordable medicines," with no enterprise software, subscription, or licensing model in the data. No parent company, external investors, funding rounds, M&A, or strategic partnerships are disclosed, and the company appears to be privately held.
Mepaco Medifood firmographics
Firmographics- Name
- Mepaco Medifood
- Legal name
- Arab Company For Pharmaceuticals and Medicinal Plants
- Website
- https://mepaco-pharma.net
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Mepaco Medifood (Arab Company For Pharmaceuticals and Medicinal Plants) is an Egypt-based pharmaceutical manufacturer producing generic medicines, herbal remedies, supplements, and baby cereals across 12 therapeutic categories for export to approximately 30 countries in Asia, Africa, and Europe.
- Ownership category
- akta.pro rank
Mepaco Medifood industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411), Food Manufacturing (311)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), Miscellaneous Food Preparations & Kindred Products (2090)
- akta.pro primary industry
- Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)
- akta.pro secondary industries
- Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium) (AFAKAJAD), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)
Keywords
Where Mepaco Medifood is headquartered
LocationHeadquarters
- HQ city
- Cairo
- HQ country
- Egypt
- HQ region
- Africa
Offices3 records
Markets served
Mepaco Medifood business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations
Revenue model
- Pharmaceutical Product Sales: Revenue generated from manufacturing and selling pharmaceutical products including herbal remedies, preparations with natural ingredients, and related healthcare products across multiple therapeutic areas.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Mepaco Medifood product offering
Product offeringCore offering
Mepaco Medifood (legally Arab Company for Pharmaceuticals and Medicinal Plants) is an Egyptian pharmaceutical manufacturer that researches, produces, and supplies a portfolio of over 100 pharmaceutical products, herbal remedies, nutritional supplements, and baby cereals. Products are organized across therapeutic categories including cardiovascular, antibiotics, CNS, respiratory, urology, metabolic/diet control, NSAIDs, immune stimulants, vitamins/minerals/antioxidants, and GIT products, and are distributed domestically and exported to approximately 30 countries.
Product overview
Mepaco Medifood (Arab Company for Pharmaceuticals and Medicinal Plants) is an Egyptian pharmaceutical manufacturer with a broad portfolio of over 100 pharmaceutical products and food supplements organized across 12 therapeutic categories. The company's core offerings include: cardiovascular medications (Losartan, Irbesartan, Valsartan, Co-Valsartan combinations, Feloblock, Coenzyme Q10, L-Carnitine products); antibiotics (Augmacillin, Mepaclind, Mepafloxin, Mepafuran); gastrointestinal products (Mepacolon, Mepasil, Mepaspasmin, Cyncholine, Ginger); NSAIDs and bone products (Inflacam, Mepacofen, Mepabrufen, Uric pure); CNS medications (Stablentin, Citalomep, Ginko products, Dormival, Mepahist); respiratory products (Broncho syrups, Guaflex, Spanomep, Vocaleive); immune stimulants (Immulant products, Immu-C); diabetic and diet control products (Mepaphage Metformin variants, Mepaco Slim, Diaglu, Mepasweet-S); vitamins and mineral supplements (Amino18, Calcium D3F, Vitamin E, Coenzyme Q10 Forte); urology products (Pepon, Nanofreq, Kellagon, L-Arginine); and baby cereals (Rice, Wheat & Milk variants). The company specializes in herbal remedies and preparations with natural ingredients, and exports to approximately 30 countries across Asia, Africa, and Europe.
Differentiator
Problem solved
Functional benefit
Products and services
- Cardiovascular Medicines
Quantifiable outcome
- Supply market with High-Quality Pharmaceutical Products at affordable prices, helping human healthcare improvement
Companies that use Mepaco Medifood
Customer profileSegments1 record
Ideal customer profiles2 records
Mepaco Medifood technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Mepaco Medifood partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
Mepaco Medifood competitors and assessment
Company assessmentDirect peers
- Amoun Pharmaceutical: Egypt-based pharmaceutical manufacturer producing generics and specialty products across multiple therapeutic categories. Comparable as a fellow Egyptian broad-portfolio manufacturer serving similar domestic and regional channels.
- EIPICO (Egyptian International Pharmaceutical Industries Co.): One of Egypt's largest pharmaceutical manufacturers with a broad portfolio across multiple therapeutic areas. Comparable as a domestic Egyptian pharma peer competing in similar generics and dosage-form categories.
- EVA Pharma: Egypt-based pharmaceutical manufacturer with a broad therapeutic portfolio and significant export presence across MENA and Africa. Directly comparable to Mepaco in product breadth, Egypt-based manufacturing, and regional generics/herbal focus.
- Pharco Pharmaceuticals: Major Egyptian pharmaceutical group with a wide therapeutic portfolio and substantial MENA/Africa export footprint. Closely aligned with Mepaco in domestic Egyptian manufacturing and broad therapeutic coverage.
Regional players
- Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer producing generics across multiple therapeutic areas for MENA markets. Comparable in broad generics portfolio and regional focus, though with primary concentration in Gulf rather than African markets.
- Spimaco (Saudi Pharmaceutical Industries & Medical Appliances Corp.): Saudi Arabia-based pharmaceutical manufacturer with broad therapeutic categories and regional Gulf/MENA distribution. Comparable as a fellow Arabic-market pharma manufacturer, though focused on Gulf rather than African export markets.
Emerging players
- Cipla: Indian-headquartered global generics manufacturer with deep presence in African and emerging markets. Comparable as a major exporter of affordable generics into the same African and Asian end-markets that Mepaco serves, though at much larger scale.
Broad incumbents
- Hikma Pharmaceuticals: Jordan-headquartered, publicly listed multinational with a large generics portfolio and significant MENA presence. Comparable as a broader incumbent competing in the same regional generic-pharma market, though with substantially greater scale and capital access.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Mepaco Medifood social profiles
Digital presenceMepaco Medifood compliance and trust
Trust signalCompliance5 records
Mepaco Medifood financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mepaco Medifood leadership team
Management profileNumber of profiles
Mepaco Medifood funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mepaco Medifood M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mepaco Medifood
What does Mepaco Medifood do?
Mepaco Medifood (legally Arab Company for Pharmaceuticals and Medicinal Plants) is an Egyptian pharmaceutical manufacturer that researches, produces, and supplies a portfolio of over 100 pharmaceutical products, herbal remedies, nutritional supplements, and baby cereals. Products are organized across therapeutic categories including cardiovascular, antibiotics, CNS, respiratory, urology, metabolic/diet control, NSAIDs, immune stimulants, vitamins/minerals/antioxidants, and GIT products, and are distributed domestically and exported to approximately 30 countries.
Is Mepaco Medifood a public or private company?
Mepaco Medifood is a private company. It is classified as unknown and is currently operating.
When was Mepaco Medifood founded?
Mepaco Medifood was founded in -1. It employs 501 to 1,000 people.
Where is Mepaco Medifood based?
Mepaco Medifood is headquartered in Cairo, Egypt, in the Africa region.
How does Mepaco Medifood make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Mepaco Medifood's main competitors?
Direct peers on record are Amoun Pharmaceutical, EIPICO (Egyptian International Pharmaceutical Industries Co.), EVA Pharma and Pharco Pharmaceuticals. Regional players are Julphar (Gulf Pharmaceutical Industries) and Spimaco (Saudi Pharmaceutical Industries & Medical Appliances Corp.). Cipla is listed as an emerging player. Hikma Pharmaceuticals is listed as a broad incumbent.
Does Mepaco Medifood have an API?
No public API is recorded for Mepaco Medifood.
What industry is Mepaco Medifood in?
Mepaco Medifood's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is AFAJAKAE, Probiotics (Strains, Spore-Formers, Synbiotic Components), with a secondary code of AFAKAJAD, Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium). Its NAICS code is 3254 and its SIC code is 2833.